LPTX icon

Leap Therapeutics
LPTX

Overview Fund Activity

48 hedge funds and large institutions have $37.8M invested in Leap Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 8 closing their positions.

Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
12
Closed
8
Calls
$23K
Puts
$11K
Net Calls
+$12K
Net Calls Change
-$15K

Top Buyers

1
SAM
1
Simplify Asset Management
Nevada
$2.72M
2
EAM
2
Exome Asset Management
New York
$264K
3
6CM
3
683 Capital Management
New York
$3.55M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$170K
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$847K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$1.19M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$0
3
ACP
3
Acuta Capital Partners
California
$310K
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$470K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$102K
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
51
Millennium Management
New York
– -$31.7K -16,187 Closed
CA
52
CoreCap Advisors
Michigan
– -$9.95K -5,074 Closed
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
– -$47 -24 Closed
Qube Research & Technologies (QRT)
54
Qube Research & Technologies (QRT)
United Kingdom
– -$12 -6 Closed
1 2
3